Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
Jui‐Yi Chen(Chung Shan Medical University Hospital), Vin‐Cent Wu(National Taiwan University Hospital), Heng‐Chih Pan(National Taiwan University), Wen-Kai Chu(National Taiwan University Hospital), Tzu-Hsuan Yeh(Chi Mei Medical Center), Chih‐Chung Shiao(Saint Mary's Hospital Luodong), Yafei Yang(Zhengzhou University), Min‐Hsiang Chuang(Chi Mei Medical Center), Chun Yin See(National Cheng Kung University Hospital)
Cited by 39
Related Papers
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
|Scientific Reports|2017|93
From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease
|International Journal of Molecular Sciences|2024|65
GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
|Nature Communications|2024|65
Enhancing anaerobic digestion of kitchen wastes via combining ethanol-type fermentation with magnetite: Potential for stimulating secretion of extracellular polymeric substances
|Waste Management|2021|54
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort
|The Lancet Diabetes & Endocrinology|2025|53